• Clinical Trials

    Beyond evidence-based, Mobio’s patient-facing mobile health platform and psychotherapeutic interventions are clinically validated through numerous rigorous trials completed, underway, and launching all over the world.

    broken image

    Locations

    broken image

  •  Mobile Health Platform Validation

    Mobio’s highly customisable and functional patient-facing mobile health platform is a versatile medical tool, clinically validated in adults and adolescents for various patient populations and use-cases. 

    Precision Psychiatry

    Population health management

    Immediate care for waitlisted patients

    Remote monitoring

    Symptom Severity Triage

  • Indications

    Mobio's technologies are being used to provide clinical solutions for a healthy and growing number of medical indications. Increasingly, we are working with academic and commercial partners to develop interventions for these and other indications. Contact us for collaboration.

    broken image

  • Clinical Partners

    Mobio is fortunate to have partnered with acclaimed research institutions from around the world. We are endlessly grateful to the nearly 200 clinicians and researchers that have played a role in R&D efforts with Mobio.

  • Funding Sources

    Mobio has secured, along with its partners above, over $6 million USD in non-dilutive funding to support dozens of clinical trials. We are grateful to the following institutions for the generous contributions.

  • Certifications

    Mobio Interactive’s digital therapeutic platform “AmDTx” is CE MDD Class I, DCB0129, and ISO 27001 certified; GDPR-, HIPAA- and PHIPA-compliant; and undergoing certification for CE MDR Class IIa, ISO 13485, ISO 9000, and ISO 82304-2.

    Mobio Interactive's digital theragnostic platform leverages computer vision and AI to objectively quantify mental wellbeing for each individual patient in real time.

    Mobio is committed to publishing as much clinical research and technology development in the peer-reveiwed literature as feasible, simultaneously protecting our freedom to operate and tradesecrets.

    Cookie Use
    We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
    Learn More